COHANCE - Swing Trade Analysis with AI Signals

Last Updated Time : 19 Sept 25, 2:15 pm

Swing Trade Rating: 2.7

📉 Technical & Momentum Overview

⚠️ Weak Momentum Signals

RSI (42.3): Bearish-neutral zone, indicating lack of strength.

MACD (5.03): Positive but flattening—momentum is weak.

Price Action: Trading below both 50 DMA (₹966) and 200 DMA (₹1,024), confirming a downtrend.

Volume Spike: Unusually high volume (~5x 1-week average) may reflect panic selling or institutional exit.

📈 Fundamental Snapshot

✅ Positives

ROCE (16.0%) & ROE (12.5%): Decent capital efficiency.

Debt-to-Equity (0.04): Very low leverage—adds margin of safety.

EPS (₹12.5): Reasonable earnings base for mid-cap pharma.

🚨 Red Flags

P/E (98.9) vs Industry PE (33.4): Extremely overvalued.

PEG (-4.80): Negative PEG suggests unreliable growth valuation.

PAT Qtr (₹58.6 Cr) vs Prev Qtr (₹134 Cr): Sharp earnings decline (–22.4%).

FII Outflow (–3.82%) & DII Outflow (–5.20%): Strong institutional exit.

52W Index (11.5%): Severe underperformance vs broader market.

🎯 Optimal Entry Price

Wait for Reversal Confirmation: Entry only above ₹970–₹980 with RSI > 50 and MACD strengthening.

Aggressive Entry: ₹900–₹910 if volume stabilizes and RSI crosses 45

🚪 Exit Strategy (If Already Holding)

Target Exit: ₹980–₹995 (near 50 DMA and resistance zone)

Stop Loss: ₹875 (below recent support and VWAP)

Exit Trigger: RSI dips below 40 or MACD turns negative

Selva, COHANCE is fundamentally promising in the CDMO space but currently in a technical downtrend with valuation stress and institutional exit. If you're considering a tactical play, tight stop-loss and alert logic are essential. Want help scripting MACD reversal alerts or building a pharma basket with better PEG and ROE filters?

Edit in a page